Metraipolis › archive › dc_130cec447208
Anti-CD19 CAR T-cell therapy for autoimmune diseases: from exploratory clinical trials to quantitative pharmacodynamic modeling development — Europe PMC PMID:42812715
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42812715
- DOI
- 10.3389/fimmu.2026.1823722
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-15T15:17:28.692Z
- SHA-256 of the archived text
d8cd9c682224c3f0b585d60751a07ec0035b2c57cf910f5d8076d172d501efff- Stable URL of this page
https://metraipolis.com/documento/dc_130cec447208
How to cite
Anti-CD19 CAR T-cell therapy for autoimmune diseases: from exploratory clinical trials to quantitative pharmacodynamic modeling development — Europe PMC PMID:42812715 — Europe PMC (en), https://europepmc.org/article/MED/42812715 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_130cec447208 (Metraipolis archive dc_130cec447208, sha256 d8cd9c682224c3f0b585d60751a07ec0035b2c57cf910f5d8076d172d501efff)
BibTeX
@misc{dc130cec447208,
title = {Anti-CD19 CAR T-cell therapy for autoimmune diseases: from exploratory clinical trials to quantitative pharmacodynamic modeling development — Europe PMC PMID:42812715},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42812715},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_130cec447208; sha256 d8cd9c682224c3f0b585d60751a07ec0035b2c57cf910f5d8076d172d501efff},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42812715. Agents can read the archived copy with the MCP tool read_document.